Dissolved as of 2013, GeneBlue Corporation was a private biotechnology company developing patented new drugs and innovative formulations for treating cancer to alleviate and save the lives of millions of patients suffering from cancer. The firm had a number of revolutionary drug candidates which may greatly benefit mankind for generations to come. Founded in December of 2006 and based in the entrepreneurial biotech hub of Southern California, GeneBlue had a strong management team with extensive experience in pharmaceutical and financial management.